Wednesday, 28 September 2016

Update with BioLargo, Inc. - Water Treatment Technology Developments and Milestones for 2016-2017

BioLargo, Inc. (OTCQB: BLGO) develops sustainable technology-based products to solve some of the most widespread problems threatening the world's supply of water, food, agriculture, healthcare and energy, according to the company's website (see here: www.BioLargo.com). SNNLive caught up with Dennis Calvert, President & CEO of BioLargo, Inc. during Media Day 2016 in New York City,  NY. 

In this video interview, Mr. Calvert and our host discuss the following topics:
- Overview of BioLargo, Inc.
- Update since our last interview (click here)
- Science of AOS Filter technology
- Developing technology for water treatment applications
- Milestones for 2016-2017
- Challenges the company faces

For more information about BioLargo, Inc., please visit www.BioLargo.com

The interview may contain forward looking statements about BioLargo, Inc. See BioLargo's periodic filings with the Securities and Exchange Commission for more complete information.


Tuesday, 20 September 2016

CEO Dennis Calvert Interview: Discussing Commercial Execution with Uptick Newswire


Dennis Calvert, CEO for BioLargo, Inc. (BLGO), returns to Uptick Network and discusses with Everett Jolly how their commercialization efforts are making huge leaps forward.
We are pleased to share the following UPTICK Network Stock Day Radio Show and Podcast content. The CEOs interviewed on Stock Day did not incur any charges for their time with Uptick CEO Everett Jolly. Uptick staff is always looking for exciting companies to bring to our interested readers and listeners. Contact us at (602) 441-3474 if you would like further information on the UPTICK Network or Uptick services.

Monday, 19 September 2016

BioLargo Closes Private Offering and Improves Balance Sheet on Its March to Commercialization


WESTMINSTER, CA--(Marketwired - Sep 19, 2016) - BioLargo, Inc. OTCQB BLGO ) announced it had closed its 2015 Unit Offering to further investments. The company also reported that with the closing of this offering and the clearing of remaining funds, its cash balance will be just over $2,100,000.
Additionally, the company announced that it had converted $250,000 of outstanding debt owing under the terms of a $300,000 secured line of credit into mandatorily convertible debt and warrant structure on terms substantially equivalent to the company's 2015 Unit Offering.
Dennis P. Calvert, President and CEO of BioLargo, stated, "We are thankful for the support by our shareholders and investors as we advance our technology and commercial efforts. Our AOS Filter System continues to garner attention from an expanding audience of industry, public funding sources, and potential strategic partners. Since our technical symposium approximately one month ago, we are experiencing a swell of attention and interest in anticipation of our first commercial pilots planned in early 2017. We are also busy advancing the automation and optimization of the system as it moves from alpha to beta in preparation of its first commercial pilots, as well as developing more operations oriented staff. Sales from our Odor-No-More subsidiary continue to improve as we build out infrastructure to support an increased focus on sales, marketing and manufacturing. We are also working closely with new distributors and agents to expand sales of our CupriDyne Clean (www.cupridyne.com) industrial odor control product. At this time, our advanced wound care products in development remain on target for 510(k) application with the FDA in early 2017. This is a great time at BioLargo and our future is bright!"
The company reported the above information on Form 8-K (link here).
About BioLargo, Inc.
BioLargo, Inc. ( OTCQB BLGO ) makes life better by delivering sustainable technology-based products that help solve some of the most widespread problems threatening the world's supply of water, food, agriculture, healthcare and energy. More information can be found about the company and its subsidiaries atwww.BioLargo.com. Its subsidiary BioLargo Water, Inc. (www.BioLargoWater.com) showcases the Advanced Oxidation Systems, including its AOS Filter System -- a product in development specifically designed to eliminate common, troublesome, and dangerous (toxic) contaminants in water in a fraction of the time and cost of current technologies. It is the winner of the Technology Star award by New Technology Magazine for its breakthrough innovation for the oil industry and is named the Technology Innovation Leader in the water treatment market by Frost & Sullivan. BioLargo also owns a 50% interest in the Isan System, which was honored with a "Top 50 Water Company for the 21st Century" award by the Artemis Project now being commercialized under a license to Clarion Water, Inc. BioLargo's subsidiary Odor-No-More Inc., features award-winning products serving the pet, equine, military supply and consumer markets, including the Nature's Best Solution® and Deodorall® brands (www.OdorNoMore.com). BioLargo's subsidiary Clyra Medical Technologies, Inc. (www.ClyraMedical.com) focuses on advanced wound care management.
Safe Harbor Statement
The statements contained herein, which are not historical, are forward-looking statements that are subject to risks and uncertainties that could cause actual results to differ materially from those expressed in the forward-looking statements, including, but not limited to, the risks and uncertainties included in BioLargo's current and future filings with the Securities and Exchange Commission, including those set forth in BioLargo's Annual Report on Form 10-K.

Tuesday, 6 September 2016

BioLargo's Science Internship Program at the University of Alberta

























Thanks for the shout out by the University of Alberta highlighting BioLargo's role in their internship program! We're proud to be a part of the team and work with such great students.

See link to newsletter here.

Monday, 29 August 2016

Why BioLargo Is Hot and Why Shares May Get Hotter

By Ryan Allway · Friday, August 26th, 2016
Investors have waited patiently as BioLargo, Inc. (OTCQB: BLGO) spent millions of dollars and many years developing a world-class water treatment technology that promises to impact the world for good. In much of the world, water equates to life, and the need for clean water has never been so critical as now. Supply challenges are exacerbated by drought, pollution from industry and agriculture, and in many cases from an aging or absent sanitation infrastructure. In developing nations, 80% of all infectious disease is caused by lack of clean water. Scores of new technologies attempt to address this issue; technologies like ultrafiltration, reverse osmosis, UV, and others help, but they are expensive and in many cases they are not sufficiently effective.
BioLargo recently showcased, to a group of stakeholders, the first pre-commercial prototype of its AOS Filter System, billed as the lowest cost and highest impact scalable clean water technology.  BioLargo’s patience in positioning the technical claims for acceptance by leading researchers, grant agencies and industrial experts is paying off and the market has taken notice.
The following chart (Figure 1) illustrates that BioLargo shares had been trading quietly under the radar until August 8, 2016 when an unexpected wave of buy orders spiked the share price to over $1.00. The influx of buy orders began to build a few days before the company showcased their first commercial prototype of what could be the biggest breakthrough in the history of the $360 billion water treatment industry.
Figure 1: BioLargo share prices spiked in August 2016





On August 15, 2016, a team of BioLargo Water researchers unveiled BioLargo’s breakthrough AOS Filter, pictured here. The AOS Filter is sensor driven and harbors a cutting-edge monitoring system that enables the AOS Filter to disinfect and decontaminate polluted water more effectively and at lower costs than all competing technologies.
BioLargo Water researchers revealed the results of hundreds of studies showcasing the AOS Filter’s water purification capabilities. This robust technology eliminates water-borne bacteria and pathogens more effectively and at a lower cost than competing advanced water treatment technologies, and can boast a safe and environmentally friendly build and operation.
The company’s Chief Science Officer, Kenneth R. Code, commented, I am particularly pleased with the expert data collection, and our presentations to potential strategic partners also help affirm scalability of the AOS technology to industrial and municipal scale.”
Dennis P. Calvert, the President & CEO of BioLargo, added, We are marching forward to impact the world for good. Science confirms our scalable AOS Filter system is more effective at disinfection than any known competing technologies at less than < 1/20th the energy (cost). Now that the Alpha unit is complete, we are able to more fully demonstrate its scalability to meet heavy industrial and municipal client needs. We are thankful for the substantial support from the Canadian federal and provincial systems as well as industry members that continue to directly support our important work. We are also thankful for our shareholders that consistently support our mission to ‘Make Life Better’ and deliver value to our stakeholders. The best of times for BioLargo is ahead.”
Industry Sectors in Need of the AOS Filter System
Municipal Drinking Water
New York Times analysis of EPA data on drinking water quality points to a tremendous need for improvements to current water treatment infrastructure, as suggested by the numerous violations of the Safe Drinking Water Act that have occurred in all 50 states American states. Shockingly, over the past 5 years more than 20 percent of the nation’s water treatment systems violated key provisions of the Safe Drinking Water Act. In the state of New York, 205 water systems violated the law by delivering tap water containing illegal amounts of bacteria since 2004. Many municipal water facilities in the United States use outdated technology and are need of considerable renovations.
Some of the large water treatment companies that provide water services to millions of U.S. residents are: American Water Works Company, Inc., (NYSE: AWK), American States Water Company (NYSE: AWR), Aqua America, Inc. (NYSE: WTR) and Veolia Environment S.A. (OTC: VEOEY).
Oil Production
Steve Mueller, CEO of Southwestern Energy Company (NYSE: SWN) estimates that water transportation, typically trucking, for a single well costs around $1.5 million, equivalent to 25% of the cost of an average Marcellus well ($6M). When oil was trading at $80-$100 per barrel, there was ample room to pay the high cost of water management, but now that the price has fallen dramatically, profit margins are upside down and high water management costs are exacerbating widespread industry losses.
The ability to recycle produced water on-site for major operators such as Exxon Mobil Corporation (NYSE: XOM), Halliburton Company (NYSE: HAL), Schlumberger Limited (NYSE: SLB), Chevron Corporation (NYSE: CVX) and Royal Dutch Shell plc (NYSE: RDS-A) could shrink transportation costs, source water costs, and disposal costs. Any technology such as the AOS Filter that could cost-efficiently enable water recycling on-site, could slash costs and greatly improve the bottom line for many producers currently suffering big losses due to low oil prices. Not only that, but it could also solve the difficult problem of pollution from Produced Water.
Maritime Industry
Increasing concerns over the detrimental transfer of invasive marine species across the world’s oceans through the transport and disposal of ballast water by large vessels have prompted the International Maritime Organization and the United States Coast Guard to impose regulations for the treatment and discharge of ballast water.
An estimated 65,000 ships, carrying over 400 gross tons, must be fitted with approved Ballast Water Treatment Systems, “BWTS”, within the next 5 years.  The approved systems must disinfect seawater without adding any toxic elements to the discharged water.  Global Water Intelligence estimates that the average cost for each system exceeds $750,000 and the total cost to outfit every vessel will be about $50 billion.
The AOS Filter is the highest impact and lowest cost technology capable of solving this problem, and is expected to provide the best solution to maritime operators such as DryShips, Inc. (NASDAQ: DRYS), Navios Maritime Holdings, Inc. (NASDAQ: NM) and Diana Shipping, Inc. (NYSE: DSX).
Poultry Processing
In an effort to reduce the incidence of foodborne illness, the U.S. Department of Agriculture’s Food Safety and Inspection Service, FSIS, announced strict new federal standards to reduce Salmonella andCampylobacter in ground chicken and turkey products, as well as in raw chicken breasts, legs, and wings.
The new regulations took effect July 1, 2016 and have the potential to impact sales of poultry processing operations of Tyson Foods, Inc. (NYSE: TSN), Pilgrims Pride Corporation, (NASDAQ: PPC), Sanderson Farms, Inc., (NASDAQ: SAFM), Hormel Foods Corporation, (NYSE: HRL), Perdue, Cargill, Smithfield Food, Inc., Conagra Foods, Inc., and every other poultry processor. Researchers at the University of Alberta confirmed that the AOS Filter could be highly effective in reducing bacterial cross-contamination at the chill-tank step of poultry processing, a common practice whereby poultry is submerged in cold water to cool it. The company is in discussions with large poultry processors.
The AOS Filter has broad applications to be a centerpiece of a complete water treatment system as well as a modular component of, or enhancing addition to systems that may already be installed that can also be used for:
  • Removal of pesticides, phosphates, and nitrates from runoff of water treatment and agriculture operations. This will reduce hazardous and costly algae blooms that are becoming prevalent globally.
  • Meeting EPA requirements for mining operations.
  • Meeting EPA requirements for nutrients and contaminants in water at steam power plants.
  • Providing livestock operations with clean and safe water that complies with EPA requirements for holding and discharge of contaminated water.
  • Storm drain recapture and reuse, a growing market opportunity in arid climates like Southern California.
BioLargo is no one-trick pony.  The company has been busy developing its technology and products for nearly a decade and it has a number of huge business opportunities that are each finding their way to market and industry acceptance.
CupriDyne Clean™ provides Unsurpassed for Odor Control
Just this May this year, BioLargo announced that its patented Cupridyne Clean outperforms every product in the (considerably large) industrial odor control sector and that the company had secured its first customers. BioLargo is expanding its sales efforts and trials that are either soon to launch or are already underway with several industries voicing a sizable unmet need.
iSan And IoMax For Poultry and Livestock Drinking Water
BioLargo’s licensee, Clarion Water, announced EPA approval for the sale of IoMax for use in poultry feed water with plans to expand into all livestock production and other agriculture-based uses. IoMax™ is highly effective in killing pathogenic microorganisms such as bacteria, viruses, fungi and potentially protozoa in water. IoMax™ is supplied through Clarion’s patented iSAN™ delivery system that doses aqueous iodine into water systems with precision.
Advanced Wound Care
BioLargo is targeting 2017 for the release of its new Advanced Wound Care products. The $6 Billion wound care industry is fragmented, with several dozen companies competing for a share of this fast-growing market. Smith & Nephew (NYSE: SNN), Derma Sciences (DSCI), Osiris Therapeutics, Inc. (OSIR), Vericel Corporation (VCEL) and Johnson & Johnson (NYSE: JNJ) are some of the companies providing wound care products to this large industry.
With the seed capital already in place and a $5 million post FDA credit facility committed by its backers, BioLargo’s subsidiary Clyra Medical Technologies has the financial resources to complete its preparations and apply for FDA approval to market its Advanced Wound Care products. When successful, Clyra has the potential to gain a meaningful portion of this substantial market that is in need of better products and technologies.
Why Is BioLargo Hot and Will Shares Get Hotter?
Its technologies have an undeniable role to play in massive commercial markets. Commercialization milestones are rapidly being met for many of the company’s innovative products, and notably itsCupriDyne Clean Industrial Odor control product has decisively found its pathway to success. As Dennis Calvert stated in his most recent quote, “The future is bright for BioLargo”.



Thursday, 25 August 2016

BioLargo Expands Infrastructure to Accommodate Growth

WESTMINSTER, CA-- (Aug 25, 2016) -  BioLargo, Inc. (OTCQB: BLGO) announced that it had entered into a new multi-year office lease of approximately 8,800 square feet of office and warehouse space.  The new facility opens official as BioLargo’s office on September 1, 2016 and is located at 14921 Chestnut St., Westminster, CA 92683.
Joe Provenzano, Vice President of Operations of BioLargo and President of Odor No More, commented, "We are excited to secure a location that will allow us to expand our manufacturing capabilities and operational support needs in order to keep up with customer demand for our products, as well as to meet our basic needs for corporate operations.” 

AJ Sexton, Vice President of Industrial Sales for Odor No More, added, “Current customers of our CupriDyne Clean Industrial Odor Eliminator (www.cupridyne.com) continue to order, and we’re acquiring new customers and starting new customer trials each month.”

Dennis P. Calvert, President and CEO of BioLargo added, “Our new industrial facility builds on the excitement from our technical symposium last week in Alberta Canada, where we introduced our ‘alpha prototype’ AOS Filter System, the lowest cost and highest impact clean water treatment system, now ready for commercial pilot testing and implementation. Our decision to expand US operational support for our odor control products is a response from the market and increasing sales.”

About BioLargo, Inc.
BioLargo, Inc. (BLGO) makes life better by delivering sustainable technology-based products that help solve some of the most widespread problems threatening the world's supply of water, food, agriculture, healthcare and energy. More information can be found about the company and its subsidiaries at www.BioLargo.com. Its subsidiary BioLargo Water, Inc. (www.BioLargoWater.com) showcases the Advanced Oxidation Systems, including its AOS Filter -- a product in development specifically designed to eliminate common, troublesome, and dangerous (toxic) contaminants in water in a fraction of the time and cost of current technologies. It is the winner of the Technology Star award by New Technology Magazine for its breakthrough innovation for the oil industry and is named the Technology Innovation Leader in the water treatment market by Frost & Sullivan. BioLargo also owns a 50% interest in the Isan System, which was honored with a "Top 50 Water Company for the 21st Century" award by the Artemis Project now being commercialized under a license to Clarion Water, Inc. BioLargo's subsidiary Odor-No-More Inc., features award-winning products serving the pet, equine, military supply and consumer markets, including the Nature's Best Solution® and Deodorall® brands (www.OdorNoMore.com). BioLargo's subsidiary Clyra Medical Technologies, Inc. (www.ClyraMedical.com) focuses on advanced wound care management.

Safe Harbor Statement
The statements contained herein, which are not historical, are forward-looking statements that are subject to risks and uncertainties that could cause actual results to differ materially from those expressed in the forward-looking statements, including, but not limited to, the risks and uncertainties included in BioLargo's current and future filings with the Securities and Exchange Commission, including those set forth in BioLargo's Annual Report on Form 10-K.

Contact:
Company Contact
Dennis Calvert
President and CEO
BioLargo, Inc.

949-643-9540 x2

widget